Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Other(2)

Detailed Status

unknown2
Recruiting2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

unknown250%
recruiting250%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

NCT07476703
recruiting

Biomarkers in the Diagnosis and Prognosis of NAFLD

NCT06098417
unknownnot_applicable

Night Hyperglycemia and Fatty Liver in Type 1 Diabetes

NCT05933018
unknown

GastrOesophageal Varices After Sustained Virological Response

NCT04191018

Clinical Trials (4)

Showing 4 of 4 trials
NCT07476703

Expanded Studies on the SCAPIS Stockholm Reexamination Cohort

Recruiting
NCT06098417

Biomarkers in the Diagnosis and Prognosis of NAFLD

Recruiting
NCT05933018Not Applicable

Night Hyperglycemia and Fatty Liver in Type 1 Diabetes

Unknown
NCT04191018

GastrOesophageal Varices After Sustained Virological Response

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4